Annual Shareholders Equity:
$377.48M-$476.00K(-0.13%)Summary
- As of today, AUPH annual stockholders equity is $377.48 million, with the most recent change of -$476.00 thousand (-0.13%) on December 31, 2024.
- During the last 3 years, AUPH annual shareholders equity has fallen by -$101.61 million (-21.21%).
- AUPH annual shareholders equity is now -21.21% below its all-time high of $479.09 million, reached on December 31, 2021.
Performance
AUPH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Shareholders Equity:
$365.77M+$30.47M(+9.09%)Summary
- As of today, AUPH quarterly stockholders equity is $365.77 million, with the most recent change of +$30.47 million (+9.09%) on September 30, 2025.
- Over the past year, AUPH quarterly shareholders equity has dropped by -$22.23 million (-5.73%).
- AUPH quarterly shareholders equity is now -23.65% below its all-time high of $479.09 million, reached on December 31, 2021.
Performance
AUPH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AUPH Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -0.1% | -5.7% |
| 3Y3 Years | -21.2% | -13.6% |
| 5Y5 Years | +26.4% | -8.3% |
AUPH Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -21.2% | at low | -13.6% | +9.1% |
| 5Y | 5-Year | -21.2% | +26.4% | -23.6% | +22.7% |
| All-Time | All-Time | -21.2% | >+9999.0% | -23.6% | >+9999.0% |
AUPH Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $365.77M(+9.1%) |
| Jun 2025 | - | $335.30M(-4.3%) |
| Mar 2025 | - | $350.19M(-7.2%) |
| Dec 2024 | $377.48M(-0.1%) | $377.48M(-2.7%) |
| Sep 2024 | - | $388.00M(+6.4%) |
| Jun 2024 | - | $364.62M(+1.4%) |
| Mar 2024 | - | $359.48M(-4.9%) |
| Dec 2023 | $377.95M(-6.8%) | $377.95M(-3.6%) |
| Sep 2023 | - | $391.88M(-0.1%) |
| Jun 2023 | - | $392.29M(+0.5%) |
| Mar 2023 | - | $390.41M(-3.7%) |
| Dec 2022 | $405.44M(-15.4%) | $405.44M(-4.2%) |
| Sep 2022 | - | $423.43M(-0.1%) |
| Jun 2022 | - | $423.77M(-5.4%) |
| Mar 2022 | - | $448.12M(-6.5%) |
| Dec 2021 | $479.09M(+17.5%) | $479.09M(+60.7%) |
| Sep 2021 | - | $298.17M(-10.3%) |
| Jun 2021 | - | $332.26M(-10.3%) |
| Mar 2021 | - | $370.23M(-9.2%) |
| Dec 2020 | $407.75M(+36.6%) | $407.75M(+2.2%) |
| Sep 2020 | - | $398.84M(+66.9%) |
| Jun 2020 | - | $239.04M(-9.3%) |
| Mar 2020 | - | $263.41M(-3.7%) |
| Dec 2019 | $298.60M(+165.2%) | $273.52M(+121.0%) |
| Sep 2019 | - | $123.74M(-1.7%) |
| Jun 2019 | - | $125.87M(-9.7%) |
| Mar 2019 | - | $139.34M(+23.8%) |
| Dec 2018 | $112.58M(-32.1%) | $112.58M(-10.2%) |
| Sep 2018 | - | $125.34M(-11.8%) |
| Jun 2018 | - | $142.17M(-6.7%) |
| Mar 2018 | - | $152.45M(-8.0%) |
| Dec 2017 | $165.74M(+361.0%) | $165.74M(-1.1%) |
| Sep 2017 | - | $167.64M(-6.1%) |
| Jun 2017 | - | $178.47M(+3.4%) |
| Mar 2017 | - | $172.66M(+380.3%) |
| Dec 2016 | $35.95M(+80.1%) | $35.95M(+78.8%) |
| Sep 2016 | - | $20.10M(+2.9%) |
| Jun 2016 | - | $19.54M(+21.9%) |
| Mar 2016 | - | $16.02M(-19.7%) |
| Dec 2015 | $19.96M(-55.7%) | $19.96M(-15.2%) |
| Sep 2015 | - | $23.54M(-16.0%) |
| Jun 2015 | - | $28.01M(+1.6%) |
| Mar 2015 | - | $27.56M(-38.9%) |
| Dec 2014 | $45.11M(+238.8%) | $45.11M(-8.5%) |
| Sep 2014 | - | $49.32M(-3.4%) |
| Jun 2014 | - | $51.07M(-6.5%) |
| Mar 2014 | - | $54.62M(+310.3%) |
| Dec 2013 | $13.31M(+728.8%) | $13.31M(+8.5%) |
| Sep 2013 | - | $12.27M(+525.3%) |
| Jun 2013 | - | -$2.89M(+1.3%) |
| Mar 2013 | - | -$2.93M(-38.2%) |
| Dec 2012 | -$2.12M | -$2.12M(-195.9%) |
| Sep 2012 | - | $2.21M(-41.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $3.76M(-38.8%) |
| Mar 2012 | - | $6.15M(-4.4%) |
| Dec 2011 | $6.43M(+0.6%) | $6.43M(-48.2%) |
| Sep 2011 | - | $12.42M(+14.4%) |
| Jun 2011 | - | $10.86M(+83.9%) |
| Mar 2011 | - | $5.90M(-7.6%) |
| Dec 2010 | $6.39M(+33.0%) | $6.39M(+7.7%) |
| Sep 2010 | - | $5.93M(+14.3%) |
| Jun 2010 | - | $5.19M(-10.5%) |
| Mar 2010 | - | $5.80M(+20.7%) |
| Dec 2009 | $4.80M(-38.1%) | $4.80M(-20.6%) |
| Sep 2009 | - | $6.05M(-14.8%) |
| Jun 2009 | - | $7.11M(+63.8%) |
| Mar 2009 | - | $4.34M(-44.1%) |
| Dec 2008 | $7.76M(-72.8%) | $7.76M(-42.6%) |
| Sep 2008 | - | $13.52M(-24.0%) |
| Jun 2008 | - | $17.78M(-21.5%) |
| Mar 2008 | - | $22.66M(-20.5%) |
| Dec 2007 | $28.51M(+41.1%) | $28.51M(-22.4%) |
| Sep 2007 | - | $36.74M(-10.8%) |
| Jun 2007 | - | $41.18M(-11.3%) |
| Mar 2007 | - | $46.42M(+129.8%) |
| Dec 2006 | $20.20M(-52.0%) | $20.20M(-27.4%) |
| Sep 2006 | - | $27.82M(-18.5%) |
| Jun 2006 | - | $34.13M(-9.8%) |
| Mar 2006 | - | $37.84M(-10.1%) |
| Dec 2005 | $42.11M(-19.6%) | $42.11M(-18.6%) |
| Sep 2005 | - | $51.76M(+32.0%) |
| Jun 2005 | - | $39.20M(-14.6%) |
| Mar 2005 | - | $45.92M(-12.3%) |
| Dec 2004 | $52.37M(-23.9%) | $52.37M(-8.3%) |
| Sep 2004 | - | $57.13M(-5.9%) |
| Jun 2004 | - | $60.69M(-6.4%) |
| Mar 2004 | - | $64.81M(-5.8%) |
| Dec 2003 | $68.78M(+45.1%) | $68.78M(-4.6%) |
| Sep 2003 | - | $72.10M(+15.9%) |
| Jun 2003 | - | $62.22M(+33.6%) |
| Mar 2003 | - | $46.56M(-1.8%) |
| Dec 2002 | $47.39M(+34.7%) | $47.39M(-5.1%) |
| Sep 2002 | - | $49.94M(+0.9%) |
| Jun 2002 | - | $49.49M(+36.9%) |
| Mar 2002 | - | $36.16M(+2.8%) |
| Dec 2001 | $35.19M(+169.8%) | - |
| Dec 2001 | - | $35.19M(+35.1%) |
| Sep 2001 | - | $26.05M(+156.9%) |
| Jun 2001 | - | $10.14M(-8.3%) |
| Mar 2001 | - | $11.06M(+1126.9%) |
| Dec 2000 | $13.04M(+307.8%) | - |
| Nov 1999 | $3.20M(+474.6%) | - |
| Aug 1999 | - | $901.40K(+8.3%) |
| May 1999 | - | $832.10K(-4.0%) |
| Feb 1999 | - | $866.70K |
| Nov 1998 | -$853.60K | - |
FAQ
- What is Aurinia Pharmaceuticals Inc. annual stockholders equity?
- What is the all-time high annual shareholders equity for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. annual shareholders equity year-on-year change?
- What is Aurinia Pharmaceuticals Inc. quarterly stockholders equity?
- What is the all-time high quarterly shareholders equity for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. quarterly shareholders equity year-on-year change?
What is Aurinia Pharmaceuticals Inc. annual stockholders equity?
The current annual shareholders equity of AUPH is $377.48M
What is the all-time high annual shareholders equity for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high annual stockholders equity is $479.09M
What is Aurinia Pharmaceuticals Inc. annual shareholders equity year-on-year change?
Over the past year, AUPH annual stockholders equity has changed by -$476.00K (-0.13%)
What is Aurinia Pharmaceuticals Inc. quarterly stockholders equity?
The current quarterly shareholders equity of AUPH is $365.77M
What is the all-time high quarterly shareholders equity for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high quarterly stockholders equity is $479.09M
What is Aurinia Pharmaceuticals Inc. quarterly shareholders equity year-on-year change?
Over the past year, AUPH quarterly stockholders equity has changed by -$22.23M (-5.73%)